Growth hormone deficiency and Cellulitis

Summary:

Cellulitis is found among people with Growth hormone deficiency, especially for people who are male, 50-59 old.

The study analyzes which people have Cellulitis with Growth hormone deficiency. It is created by eHealthMe based on reports of 33 people who have Growth hormone deficiency from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Growth hormone deficiency?

Growth hormone deficiency is found to be associated with 45 drugs and 221 conditions by eHealthMe. Check the latest studies of Growth hormone deficiency.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,078 drugs and 2,340 conditions by eHealthMe. Check the latest studies of Cellulitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

33 people who have Growth Hormone Deficiency and Cellulitis are studied.

Would you have Cellulitis when you have Growth hormone deficiency?

Gender of people who have Growth Hormone Deficiency and experienced Cellulitis *:

female: 30 %
male: 70 %

Age of people who have Growth Hormone Deficiency and experienced Cellulitis *:

Common co-existing conditions for these people *:

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 7 people, 21.21%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 4 people, 12.12%
Blood Thyroid Stimulating Hormone Decreased: 3 people, 9.09%
Type 2 Diabetes: 2 people, 6.06%
Immune System Disorder: 2 people, 6.06%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 6.06%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 3.03%
Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 1 person, 3.03%
Nausea (feeling of having an urge to vomit): 1 person, 3.03%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 3.03%

Common drugs taken by these people *:

Common symptoms for these people *:

Joint Pain: 5 people, 15.15%
Infection: 5 people, 15.15%
Fatigue (feeling of tiredness): 5 people, 15.15%
Weakness: 4 people, 12.12%
Pain: 4 people, 12.12%
Device Related Infection: 3 people, 9.09%
Joint Swelling: 3 people, 9.09%
Joint Effusion (presence of extra fluid in joint covering): 3 people, 9.09%
Injection Site Erythema (redness at injection site): 3 people, 9.09%
Gait Disturbance: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

Related studies:

Treatments, associated drugs and conditions:

Growth hormone deficiency (21,584 reports)
Cellulitis (75,291 reports)

All the drugs that are associated with Cellulitis:

Cellulitis (2,078 drugs)

All the conditions that are associated with Cellulitis:

Cellulitis (2,340 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cellulitis and Growth hormone deficiency, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.